Education
About Us
Working with TipRanks
Follow Us
CellSource Co., Ltd. (JP:4880)
:4880
4880 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥556.00 - ¥1,568.00
Previous CloseN/A
Volume210.70K
Average Volume (3M)43.23K
Market Cap
¥13.34B
Enterprise Value¥9.02B
Total Cash (Recent Filing)¥4.39B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)284.5
Beta0.63
Next Earnings
Sep 11, 2025EPS EstimateN/A
Next Dividend Ex-Date
Oct 30, 2025Dividend Yield0.75%
Share Statistics
EPS (TTM)2.86
Shares Outstanding19,816,362
10 Day Avg. Volume34,660
30 Day Avg. Volume43,233
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥742.00Price Target Upside11.41% Upside
Rating ConsensusHold
Number of Analyst Covering0
CellSource Co., Ltd. News
4880 FAQ
What was CellSource Co., Ltd.’s price range in the past 12 months?
CellSource Co., Ltd. lowest stock price was ¥556.00 and its highest was ¥1568.00 in the past 12 months.
What is CellSource Co., Ltd.’s market cap?
CellSource Co., Ltd.’s market cap is ¥13.34B.
When is CellSource Co., Ltd.’s upcoming earnings report date?
CellSource Co., Ltd.’s upcoming earnings report date is Sep 11, 2025 which is in 22 days.
How were CellSource Co., Ltd.’s earnings last quarter?
CellSource Co., Ltd. released its earnings results on Jun 12, 2025. The company reported ¥2.86 earnings per share for the quarter, beating the consensus estimate of N/A by ¥2.86.
Is CellSource Co., Ltd. overvalued?
According to Wall Street analysts CellSource Co., Ltd.’s price is currently Undervalued.
Does CellSource Co., Ltd. pay dividends?
CellSource Co., Ltd. pays a Annually dividend of ¥5 which represents an annual dividend yield of 0.75%. See more information on CellSource Co., Ltd. dividends here
What is CellSource Co., Ltd.’s EPS estimate?
CellSource Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CellSource Co., Ltd. have?
CellSource Co., Ltd. has 19,816,362 shares outstanding.
What happened to CellSource Co., Ltd.’s price movement after its last earnings report?
CellSource Co., Ltd. reported an EPS of ¥2.86 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.817%.
Which hedge fund is a major shareholder of CellSource Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4880
Company Description
CellSource Co., Ltd.
CellSource Co., Ltd. (4880) is a biotechnology company specializing in regenerative medicine and cell therapy solutions. The company focuses on the development and commercialization of cutting-edge treatments using stem cell technology, particularly for diseases and conditions that currently have limited therapeutic options. Their core services include the collection, processing, and storage of stem cells, as well as research and development of new regenerative therapies.
Technical Analysis
StemRIM Inc.
―
STELLA PHARMA CORPORATION
―
ReproCELL Inc.
―
StemCell Institute
―
CellSeed Inc.
―
Ownership Overview
―
Insiders
0.02%
Mutual Funds
― Other Institutional Investors
99.88% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---